MDLN Medline Inc.

P/E 37.23
Forward P/E 28.33
Price/Sales 2.595
Beta --
Div Yield --
Market Cap --

Company Analysis

Latest News

Medline Initiates Market Exit for Bed Products, Estimates Costs Up to $220 Million

Medline Inc. has initiated a voluntary field action to remove, discontinue, and exit the market for all of its Medline Brand beds. The action, which began on...

Egerton Capital Reduces Medline Stake by 19%

John Armitage's Egerton Capital disclosed a significant reduction in its holdings of MEDLINE INC (MDLN), cutting its position by 19.35% to 13.28 million...

Durable Capital Slashes Medline (MDLN) Stake by Nearly 64%

Henry Ellenbogen's Durable Capital significantly reduced its investment in Medline Inc. (MDLN) during the second quarter of 2026, cutting its holdings by...

Egerton Capital boosts stake in medical supplier Medline (MDLN)

John Armitage's Egerton Capital significantly increased its position in medical supplies manufacturer and distributor Medline Inc. (MDLN), according to a...

Viking Global Reduces MEDLINE INC (MDLN) Stake by Over 57%

Andreas Halvorsen's Viking Global Investors significantly cut its position in MEDLINE INC (MDLN) by 57.66% during the second quarter of 2026. According to a...

Lone Pine Capital boosts stake in Medline (MDLN) by 78%

Stephen Mandel's Lone Pine Capital significantly increased its position in medical supply company Medline Inc. (MDLN), according to a recent quarterly...

Steve Cohen's Point72 Exits $147M Stake in Medline Inc.

In a recent 13F filing, Steve Cohen's Point72 revealed it had completely exited its position in medical supply company Medline Inc. (MDLN) during the second...

Medline's second quarter revenue grew 11.6% to $7.7B, but FY26 profit guidance was lowered on rising costs.

Medline reported second quarter revenue of $7.7 billion, up 11.6% year-over-year, and Adjusted EPS of $0.50, beating consensus estimates of $7.51 billion and...

Medline Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026

Analysts anticipate Medline Inc. (MDLN) will report Q2 2026 consensus revenue of $7.51 billion and EPS of $0.32, with shares currently trading at $39.28...

Medline Chief Operating Officer Stephen L. Miller Announces Retirement

Medline Inc. announced that Chief Operating Officer (COO) Stephen L. Miller will retire from his position for health-related reasons. The company has initiated...

Medline Inc. Q1 2026 Earnings Preview: What Analysts Expect on May 13, 2026

Consensus estimates for Medline Inc. point to revenue of $7.13 billion and earnings of $0.29 per share, with the stock currently trading at $44.19 against an...

Medline beats first quarter 2026 revenue estimates with 10.7% growth and raises sales guidance, though profits declined.

Medline reported first quarter 2026 net sales of $7.4 billion, a 10.7% increase year-over-year, and adjusted diluted EPS of $0.33. While sales growth was...

Medline Inc. Q1 2026 Earnings Preview: What Analysts Expect on May 06, 2026

Analysts expect Medline to report Q1 2026 revenue of $7.16 billion and EPS of $0.29, with the stock currently trading at $44.75 against an average price target...

Medline's fourth quarter revenue grew 14.8% to $7.8B, but net income fell 38% due to higher costs.

Medline's fourth quarter revenue grew 14.8% to $7.8B, but net income fell 38% due to higher costs.

Medline reported fourth quarter 2025 revenue of $7.8 billion, a 14.8% increase year-over-year, while net income declined 37.7% to $180 million. For the full...

MEDLINE INC - CLASS A Reports Q4 2025 Earnings on February 25, 2026

For the fourth quarter of 2025, consensus estimates for Medline Inc - Class A are pegged at $7.52 billion in revenue and $0.24 in EPS, with the stock currently...